Position in RNAC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,206
+$123,206 QoQ
Shares Held
11,824
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 95 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNAC Over Time
Shares Held
Position Value (USD)
Derivatives in RNAC
reported options exposure · as of Jun 30, 2026CallValue
$141,712
CallShares
13,600
PutValue
$112,536
PutShares
10,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. RNAC ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in RNAC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,206 | 11,824 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $112,536 | 10,800 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $141,712 | 13,600 | Call | Defined | 2026-08-14 | |
| 2025-12-31 | $137,711 | 19,100 | Put | Defined | 2026-02-12 | |
| 2024-03-31 | $123,637 | 190,211 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $59,050 | 85,704 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $17,477 | 15,605 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $250,252 | 180,038 | Shares | Defined | 2023-05-16 | |
| 2022-09-30 | $62,693 | 38,228 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $43,740 | 33,390 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $13,834 | 11,248 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $267,991 | 82,206 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $50,152 | 12,056 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $245,365 | 58,700 | Call | Defined | 2021-08-16 | |
| 2021-06-30 | $102,016 | 24,406 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $42,104 | 13,896 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $51,519 | 20,774 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $478,505 | 168,488 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $253,176 | 105,053 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||